Femasys stock.

Jun 18, 2021 · In addition, Femasys has granted the underwriters a 30-day option to purchase an additional 397,500 shares of its common stock at the initial public offering price, less the underwriting discounts ... Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.Femasys’ FemBloc ® permanent birth control in late-stage clinical development is the first and only non-surgical, in-office, permanent birth control method intended to be a safer option for ...At Femasys Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.FEMY - Femasys Inc Stock Price and Quote Nov-23-23 03:38PM 20 Countries with the Highest Teenage Pregnancy Rates (Insider Monkey) Nov-15-23 08:30AM PharmaCyte …Web

Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.Femasys Inc. Common Stock (FEMY) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Femasys stock price prediction is an act of determining the future value of Femasys shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Femasys' future price could yield a significant profit. Please, note that this module is not intended to be used solely to …

Stock Info Stock Quote Price $1.03 Volume 3,368,658 Change +0.12 % Change +12.72% Today's Open $0.96 Previous Close $0.91 Intraday High $1.14 Intraday …WebFemasys Inc (FEMY) stock is trading at $1.10 as of 10:08 AM on Wednesday, Nov 15, an increase of $0.17, or 18.28% from the previous closing price of $0.93. The stock has traded between $1.05 and $1.25 so far today. Volume today is 2,748,419 compared to average volume of 3,456,068.

Under the terms of the investment, the investors were also issued two series of warrants: warrants to purchase approximately 5.8 million shares of common stock at an exercise price of $1.18 per ...Femasys Inc.is a biomedical company focused on transforming women's healthcare by developing novel solutions as well as providing significant clinical impact to address severely underserved areas. The company's lead product candidates offer FemBloc and FemaSeed. Femasys Inc. is based in ATLANTA. Stock split history for Femasys since 2021.Electronic Technology. Industry. Electronic Equipment/Instruments. No executives to display. Corporate headquarters. --, --. Find real-time FEMY - Femasys Inc stock quotes, company profile, news ...The Zacks Consensus Estimate for Femasys’ sales in the third quarter of 2023 is pegged at $0.4 million. However, sales in the United States declined year over year in the second quarter of 2023 ...

Oct 3, 2023 · Femasys Inc. FEMY shares are trading lower Tuesday. The stock has been volatile since the company received FDA 510(k) clearance for FemaSeed, an infertility treatment, towards the end of September .

FEMY : 1.2200 (+0.83%) Femasys to Participate in the Women’s Health Panel Discussion Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, July 13th at 11 a.m. ET Globe Newswire - Mon Jul 11, 2022. ATLANTA, July 11, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by ...

Apr 19, 2023 · In a concurrent private placement, Femasys has also agreed to issue and sell unregistered warrants to purchase up to an aggregate of 3,196,722 shares of common stock. The offering is expected to close on or about April 20, 2023, subject to the satisfaction of customary closing conditions. Femasys Inc. is a biomedical company focused on meeting women’s unmet needs worldwide by developing a broad portfolio of innovative product candidates and products that include minimally ...146.71. +1.95%. 45.70M. View today's Femasys Inc stock price and latest FEMY news and analysis. Create real-time notifications to follow any changes in the live stock price.Get Femasys Inc (FEMY) share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, and financial report.Sep 26, 2023 · That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ... Femasys Inc. announced that it has received $6.85 million in funding from PharmaCyte Biotech, Inc. and other investors Nov. 21: CI Femasys Inc. Appoints Joshua Silverman as Director Nov. 21: CI Femasys Inc. announces tranche update Nov. 16: CIFemasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical OfficerWeb

Femasys Inc, a medical technology company, has been attracting attention from investors due to its positive stock performance on October 2, 2023. According to data from CNN Money, the company has received favorable price forecasts from four analysts, with a median target of $8.50. The high estimate is $13.00, while the low estimate is $5.00.Dec 1, 2023 · Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners. Oct 4, 2023 · Publish : 04 Oct 2023, 07:17 PM Update : 04 Oct 2023, 07:17 PM. Femasys (NASDAQ: FEMY) stock is down 50% over night from highs. A reasonable bet would be that FEMY stock will continue to fall back to more reasonable levels. For, as far as we can see at least, this is a flurry of speculation producing far too much movement for the objective ... Nasdaq 14,272.37 +1.04% Crude Oil 78.16 +2.99% US 10 Yr 100.69 +2,184.99% Euro 1.09 +0.31% Dow Jones 35,124.97 +0.51% Russell 2000 1,805.52 …Web3 equities research analysts have issued twelve-month price targets for Femasys' shares. Their FEMY share price targets range from $7.00 to $10.00. On average, they expect the company's stock price to reach $9.00 in the next year. This suggests a possible upside of 884.9% from the stock's current price. View analysts price targets for FEMY or ...About Femasys Inc · Most Popular · Stocks Rankings for FEMY · Femasys Inc Vitals · Femasys Inc Competitors - Telecommunications Equipment · Top Movers Daily change%.Femasys Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023. Nov. 14. CI. Earnings Flash (FEMY) FEMASYS Reports Q3 Revenue $86,186. Nov. 14. MT. Femasys Inc. announced that it expects to receive $6.85 million in funding from PharmaCyte Biotech, Inc. Nov. 13.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Back. Femasys Inc. (FEMY) Add to watchlist. NasdaqCM - NasdaqCM Real Time Price. Currency in USD. 1.0300 +0.1162 (+12.72%) At close: …

Shares Outstanding 21.65 M Public Float 19.48 M Yield FEMY is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23) …WebDec 2, 2023 · Femasys Inc (NASDAQ:FEMY) trade information. Femasys Inc (FEMY) registered a -2.33% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.33% in intraday trading to $0.93 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -9.71%, and it has moved by -33.09% in ... FEMY Femasys Bull Pennant On 7/13/2021 Jonestrading brokerage Initiated Coverage with a Buy rating and a $8.45 Price Target On 7/13/2021 Chardan Capital brokerage Initiated Coverage with a Buy rating and a $25.00 Price Target How do you explain such a big difference in valuation? Gainers telesis bio (nasdaq:tbio) shares increased by 32.5% to $0.53 during wednesday's after-market session. Femasys shares rose 19.28% and axcella health shares rose 13.1%. Gyre therapeutics stock decreased by 8.67% and impel pharmaceuticals declined by 13.3%.26 sept 2023 ... Femasys investors are celebrating on Tuesday after the company got approval from for its infertility treatment. This has FEMY stock rising.Femasys Inc. (FEMY) delivered earnings and revenue surprises of -8.70% and 13.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?Femasys (FEMY) shares fell 13% premarket on Wednesday after the biomedical company announced an offering to raise $3.9M.The company is selling 3,196,722 shares of common stock (or...Overview. Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health.

Femasys Inc FEMY shares surged after the company received FDA 510 (k) clearance for FemaSeed, an infertility treatment designed to deliver sperm directly to where conception occurs in a woman's fallopian tube. Infertility has affected an increasing number of women – estimated at 10 million in the U.S., according to the Center for Disease Control.

View Our Latest Stock Analysis on FEMY. Femasys Price Performance. FEMY opened at $0.96 on Monday. The business has a fifty day moving average of $1.25 and a 200 day moving average of $0.81. Femasys has a 52-week low of $0.25 and a 52-week high of $4.75. The company has a quick ratio of 8.28, a current ratio of 4.68 and a …

FemBloc® patent application provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth controlATLANTA, July 27, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ ...Femasys Inc. FEMY shares are trading lower Tuesday. The stock has been volatile since the company received FDA 510(k) clearance for FemaSeed, an infertility treatment, towards the end of September .The stock of Femasys Inc (FEMY) has seen a -20.00% decrease in the past week, with a -27.78% drop in the past month, and a 152.43% flourish in the past quarter. The volatility ratio for the week is 12.52%, and the volatility levels for the past 30 days are at 13.78% for FEMY. The simple […]Femasys Inc. Announces Financial Results for the Second Quarter Ended June 30, 2023 and Provides Corporate Update. August 10, 2023 08:00 ET ... Common stock, $.001 par, ...Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p.m. ET to 3:30 p.m. ET of the following day.Femasys (FEMY) stock price is up 1,250% but there are 2 key risks. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre-mar... 7 weeks ago - Invezz.Femasys (FEMY) Short Interest Ratio and Volume 2023. DOW 35,390.15. QQQ 389.51. Turned down for a loan, business owners look to family and even crowdsourcing to get money to grow. Important info on NVDA trade (Ad) 12 crew members are missing, 1 dead after a cargo ship sinks off a Greek island in stormy seas.About Femasys Inc · Most Popular · Stocks Rankings for FEMY · Femasys Inc Vitals · Femasys Inc Competitors - Telecommunications Equipment · Top Movers Daily change%.Short interest for Femasys gives investors a sense of the degree to which investors are betting on the decline of Femasys's stock. Short interest data is updated every two weeks.

Femasys Inc. is a biomedical company focused on meeting women’s unmet needs worldwide by developing a broad portfolio of innovative product candidates and products that include minimally ...Femasys Inc. (FEMY) Stock Historical Prices & Data - Yahoo Finance S&P 500 Dow 30 Nasdaq Russell 2000 Femasys Inc. (FEMY) NasdaqCM - NasdaqCM Real Time Price. …WebZacks Rank: FEMY currently carries a Zacks Rank #3. Femasys Inc. Price and Consensus. Femasys Inc. price-consensus-chart | Femasys Inc. Quote. Stocks to Consider. Here are some stocks in the same ...Instagram:https://instagram. free unusual options activity scanneracciones de tesla hoyiyf stockyyy stock dividend Femasys, a medical device company, is set to launch its minimally invasive reproductive health products for women in 2024. ... Its stock ran from $0.33 to an …WebFemasys to Participate in the H.C. Wainwright 25th Annual Global Investment Conference. 08/31/2023. Femasys Inc. Obtains Medical Device Establishment License from Health Canada. 08/10/2023. Femasys Inc. Announces Financial Results for the Second Quarter Ended June 30, 2023 and Provides Corporate Update. 08/03/2023. trade funding companiesauto trade stocks Femasys Inc, a medical technology company, has been attracting attention from investors due to its positive stock performance on October 2, 2023. According to data from CNN Money, the company has received favorable price forecasts from four analysts, with a median target of $8.50. The high estimate is $13.00, while the low estimate is $5.00.Wall Street’s analysts know that buying low is part of a winning stock strategy, and they’ve been looking for stocks that are low – undervalued, and possibly hitting bottom. It’s the first step in an old formula for success, with the next, of course, being to sell high. Some recent picks from the analyst corps, pulled up via the TipRanks platform, may raise … ubs credit card Nov 15, 2023 · Femasys-stock; News for Femasys Femasys; ... warrants to purchase approximately 5.8 million shares of common stock at an exercise price of $1.18 per share expiring one year from issuance and ... Femasys' (FEMY) revenues in third-quarter 2023 are expected to have been driven by the higher international sales of its marketed products. ... Femasys Inc. Quote. Stocks to Consider.Ratings analysis incomplete due to data availability. Recommendations not provided. Maximize Income Goal. See Best High Dividend Stocks Model Portfolio for our ...